Biotech Volatile Stocks: Achillion Pharmaceuticals (NASDAQ:ACHN) , ZIOPHARM Oncology (NASDAQ:ZIOP) , CytRx Corporation (NASDAQ:CYTR), Cytokinetics (NASDAQ:CYTK)

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) flew up 6.90%, the company recently reported that two oral presentations were made at the 23rd Asian Pacific Association for the Study of the Liver Conference 2014 in Brisbane, Australia. Updated Phase 2 clinical trial results evaluating a 150 mg loading dose followed by 50 mg once daily of ACH-3102 in combination with either once daily 200 mg or 400 mg of sovaprevir and twice daily ribavirin showed that 100% of patients achieved SVR12 including subjects who had Y93 mutations at baseline. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares after opening at $2.68 moved to $3.11 on last trade day and at the end of the day closed at $3.08.Company price to cash ratio as 2.45. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) showed a positive weekly performance of 12.41%.

Zacks Investment Research upgraded ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) to Zacks Rank #1 (Strong Buy). ZIOPHARM’s loss estimates have declining on the back of better-than-expected fourth quarter 2013 results. ZIOPHARM’s fourth quarter 2013 loss per share of 7 cents was narrower than the Zacks Consensus Estimate of a loss of 14 cents and 85.4% below the year-ago loss. ZIOPHARM Oncology Inc.(NASDAQ:ZIOP) shares advanced 8.26% in last trading session and ended the day on $3.80. ZIOP return on equity ratio is recorded as -207.30% and its return on assets is 3.00%. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) yearly performance is -180.70%.

CytRx (NASDAQ:CYTR) was the target of a large decrease in short interest during the month of January. As of March 31st, there was short interest totalling 8,105,141 shares, a decrease of 14.8% from the March 14th total of 9,516,436 shares, AnalystRatings.NET reports. Based on an average daily volume of 2,208,569 shares, the short-interest ratio is currently 3.7 days. Currently, 17.4% of the company’s shares are short sold. CytRx Corporation (NASDAQ:CYTR) shares moved up 3.23% in last trading session and was closed at $3.20, while trading in range of $ 3.01 – 3.32. CytRx Corporation (NASDAQ:CYTR) year to date (YTD) performance is -48.96%.

Cytokinetics, Incorporated (NASDAQ:CYTK) was a big mover last session, as its shares rose nearly 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $8.51 to $9.90 in the past one-month timeframe. Cytokinetics, Inc. (NASDAQ:CYTK) weekly performance is 26.35%. On last trading day company shares ended up $11.94. Cytokinetics, Inc. (NASDAQ:CYTK) distance from 50-day simple moving average (SMA50) is 24.32%. Analysts mean target price for the company is $22.71.